Analysts' recommendations: Avinger, Inc.

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
19/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	Avinger : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

More recommendations

Managers and Directors: Avinger, Inc.

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	05/08/2024

More insiders

Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq 08:00:00 15/02/25 am AEDT			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.35M 2.2M 2.01M 3.77M 258M 3.83M 25.9M 10.11M 129M 10.16M 9.94M 431M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.12M 10.42M 9.5M 17.88M 1.22B 18.17M 123M 47.91M 613M 48.16M 47.11M 2.04B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
11/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
11/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
11/02/25	Avinger, Inc. Announces Executive Changes	CI
25/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
25/12/24	US Futures Tread Water Ahead of Holiday Break	MT
24/12/24	Iberdrola Completes Merger with Avangrid	MT
08/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
08/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
08/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
08/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
08/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Avinger, Inc. Stock

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news : Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
23/1/25	Himanshu Patel	Sell	Founder	2,215	0.0669%
23/1/25	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%
23/1/25	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-94.57%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-1.10%	-1.54%	-16.60%	-18.03%	13.44B
IRAY GROUP	+3.51%	+7.01%	+41.17%	+8.67%	4.39B
SONOSCAPE MEDICAL CORP.	+0.39%	+3.78%	-39.42%	-50.95%	1.31B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-0.69%	-0.17%	-35.34%	-38.92%	1.21B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+10.99%	+36.55%	-27.69%	-	1.17B
IRADIMED CORPORATION	-0.27%	-4.44%	+22.76%	+83.22%	1.12B
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-7.01%	+2.40%	+49.22%	+145.48%	636M
CAPSOVISION, INC.	-1.02%	-1.59%	+66.83%	-	343M
FISCHER MEDICAL VENTURES LIMITED	+1.71%	+2.47%	-60.96%	+290.00%	257M
Average	-1.50%	+4.45%	-0.00%	+40.61%	2.39B
Weighted average by Cap.	+0.35%	+0.05%	-4.39%	-2.59%

	2022	2023
Net sales	8.27M 7.17M 6.72M 6.13M 11.53M 790M 11.72M 79.15M 30.9M 395M 31.06M 30.39M 1.32B	7.65M 6.63M 6.22M 5.67M 10.67M 730M 10.84M 73.21M 28.58M 366M 28.73M 28.11M 1.22B
Net income	-17.62M -15.28M -14.32M -13.06M -24.57M -1.68B -24.96M -169M -65.83M -842M -66.16M -64.73M -2.81B	-18.32M -15.88M -14.89M -13.57M -25.54M -1.75B -25.95M -175M -68.43M -875M -68.78M -67.29M -2.92B
Net Debt	1.76M 1.52M 1.43M 1.3M 2.45M 168M 2.49M 16.8M 6.56M 83.89M 6.59M 6.45M 280M	10.12M 8.77M 8.22M 7.5M 14.11M 966M 14.33M 96.82M 37.8M 483M 37.99M 37.17M 1.61B

3 years	0.36	14
5 years	0.36	288.9
10 years	0.36	618,002.47